Chief Executive Officer & Director
CurrentLigand is a high-growth company with economic rights to some of the world's most important medicines.
Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Todd Davis is listed as CEO, Ligand Pharmaceuticals | Life Sciences Executive & Investor at Ligand Pharmaceuticals, based in Jupiter, Florida, United States. AeroLeads shows a matched LinkedIn profile for Todd Davis.
Todd Davis previously worked as Chief Executive Officer & Director at Ligand Pharmaceuticals and Director at Ligand Pharmaceuticals. Todd Davis holds Mba, Business from Harvard University.
This section adds company-level context without repeating Todd Davis's masked contact details.
Review company-level records connected to Todd Davis before choosing the right outreach path.
I am a life sciences executive with more than 30 years of operational and investment experience. Throughout my career, I have created eight pharma businesses and a royalty/credit focused investment business that has raised over $5bn. I have also been personally involved in over $4bn in healthcare financings, including growth equity, public equity turnarounds, structured debt and royalty acquisitions. I have also led, structured and closed over 40 additional IP licenses, as well as royalty-debt deals and have restructured and turned around multiple private and public companies.With insight from pharmaceutical industry commercial and operational roles, exceptional deal-making experience and an understanding of capital markets, I partner with life science experts to realize value in assets that have high potential, are emerging, have been undercapitalized, misunderstood or undervalued. This strategy allows me to consistently achieve exceptional value and investor returns. My early roles at Abbot Laboratories and Elan Pharmaceuticals gave me excellent operational experience in healthcare technology. Moving to Private Equity and my time with Apax Partners represented a steep learning curve as well as a pivotal stage in my career. I instigated the firm’s entry into the specialty pharmaceutical sector and commercial stage investing; highlights included average equity returns of greater than 40% IRR in primary deals associated with new investment areas. Since then, I’ve been at the vanguard of innovation and growth in the industry, with extensive experience across both development and commercial-stage business investments. Subsequent to Apax, I co-founded Healthcare Royalty Partners and Royalty Rx Capital and have pioneered project and royalty finance in the biopharmaceutical sector. Structure is just the tool though - what really matters are assets, science and management. I enjoy working with experienced life science clinicians and executives who are launching, acquiring, or restructuring business ventures with high-potential products and technologies.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Jupiter, Florida, US
Ligand is a high-growth company with economic rights to some of the world's most important medicines.
Jupiter, Florida, US
High-growth company that has aggregated economic rights to some of the world's most important medicines.
London, GB
Founding board member of this start-up gene therapy business that manufactures viral vectors and gene-modified cells, enabling safe and swift transition from laboratory to clinical trials and scalable processes.
Financing and development of low-risk assets with high clinical value to improve the quality of life for patients with rare and underserved diseases.
Biopharma Investment Fund, syndicating family office capital for high return/low risk special situations.
Wayne, PA, US
Founding board member of this private biopharmaceutical business serving patients with debilitating, rare genetic diseases through development and commercialization of life-changing, pathogenetically targeted therapies.
South San Francisco, California, US
Board member of this innovative oral vaccine company. Vaxart’s proprietary VAAST™ oral vaccine platform uses state-of-the-art recombinant technology that allows modular creation of a wide range of vaccines.
Commercial stage specialty pharmaceutical company dedicated to patients living with chronic pain.
Stamford, Connecticut, US
Investment firm that purchases royalties and uses debt-like structures to invest in commercial or near-commercial stage assets.
San Francisco, CA, US
Private Equity investment firm made up of a fund of funds, secondary investments and a healthcare direct investment business.
GB
UK headquartered invernational Private Equity company that creates value by supporting transformational improvements in portfolio companies.
Dublin 2, IE
International pharmaceutical company based in Dublin, Ireland, which had major interests in the United States and was listed on the New York Stock Exchange.
Quick answers generated from the profile data available on this page.
Todd Davis works for Ligand Pharmaceuticals.
Todd Davis is listed as CEO, Ligand Pharmaceuticals | Life Sciences Executive & Investor at Ligand Pharmaceuticals.
Todd Davis is based in Jupiter, Florida, United States while working with Ligand Pharmaceuticals.
Todd Davis has worked for Ligand Pharmaceuticals, Virocell Biologics, Benuvia Holdings Inc., Royaltyrx Capital, Llc, and Palvella Therapeutics.
You can use AeroLeads to view verified contact signals for Todd Davis at Ligand Pharmaceuticals, including work email, phone, and LinkedIn data when available.
Todd Davis holds Mba, Business from Harvard University.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts